OPKO Health, Inc.: OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces financial ...
It’s the body’s normal response to infection or injury — but chronic inflammation can lead to health issues. Here’s where inflammation can go wrong and tips for preventing it.
MIAMI, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and 12 months ended December 31, 2025, and introduces ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
Project documents will be available for public viewing from February 18, 2026, to March 23, 2026, at Tingley Library, 111 2nd ...
Objectives To examine outcomes from respiratory pathogens containment strategies focused on international travellers. Design We developed a compartmental model generalisable to respiratory infectious ...
Sanofi reported new real-world evidence showing that immunization with Beyfortus can significantly reduce RSV-related hospitalizations not only during an infant’s first RSV season but also into the ...
Students can prepare for the CBSE Class 12 Biology Board Exam 2026 with this comprehensive guide. Access official syllabus, previous year papers, sample papers, and deleted topics from here.
Review by Indian researchers notes that body’s immune cells ‘betray’ it to help breast cancer spread
A growing body of research is reshaping how scientists understand breast cancer—not just as a disease of rogue tumour cells, but as one that cleverly recruits the body’s own immune system to survive ...
Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering immune receptors that normally receive weak signals from tumors, these four ...
Travis Gettys is a senior editor for Raw Story based in northern Kentucky. He previously worked as a web editor for WLWT-TV and a contributing writer for the Kentucky Enquirer, and he also wrote for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results